{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001401914","name":"Dare Bioscience, Inc.","summary":"Dare Bioscience is a female-led women's health biotech company developing evidence-based solutions across contraception, sexual health, menopause, pelvic pain, fertility, vaginal health, and infectious disease. Its portfolio includes FDA-approved XACIATO (clindamycin vaginal gel for bacterial vaginosis), commercialized DARE to PLAY Sildenafil Cream, and pipeline candidates including Ovaprene (Phase 3 contraceptive), Sildenafil Cream 3.6% for FSAD, DARE-HRT1, and DARE-HPV. The company pursues FDA approval, Section 503B compounding, and consumer health product pathways.","people":[],"products":[{"name":"XACIATO","type":"service","description":"FDA-approved clindamycin phosphate vaginal gel 2% for bacterial vaginosis in females 12 years and older; single-dose prescription medication approved December 2021."},{"name":"DARE to PLAY Sildenafil Cream","type":"hardware","description":"Topically applied sildenafil formulation designed to improve female sexual arousal; commercialized December 2025 via Section 503B compounding."},{"name":"DARE to RESTORE Flora Sync LF5","type":"service","description":"Vaginal probiotic suppository consumer health product; expected U.S. commercial availability in Q2 2026."},{"name":"Ovaprene","type":"hardware","description":"Investigational hormone-free monthly intravaginal contraceptive currently in pivotal Phase 3 clinical study."},{"name":"Sildenafil Cream, 3.6%","type":"service","description":"Novel cream formulation of sildenafil for treatment of female sexual arousal disorder (FSAD); in clinical development."},{"name":"DARE-HRT1","type":"hardware","description":"Intravaginal ring delivering combination bio-identical estradiol and progesterone over 28 days for menopausal vasomotor symptoms."},{"name":"DARE-HPV","type":"service","description":"Fixed-dose lopinavir and ritonavir soft gel vaginal insert for clearance of persistent high-risk HPV infection; self-administered therapy."}],"partnerships":[{"partner_name":"Organon International GmbH","partnership_type":"licensing","description":"Organon holds exclusive worldwide rights to develop, manufacture, and commercialize XACIATO under a 2022 license agreement.","start_date":null},{"partner_name":"XOMA (US) LLC","partnership_type":"strategic","description":"In April 2024, Dare sold its XACIATO royalty and milestone payment rights to XOMA until XOMA achieves a specified return.","start_date":null},{"partner_name":"Bravado Pharmaceuticals, LLC","partnership_type":"development","description":"Manufactures DARE to PLAY Sildenafil Cream and fulfills prescriptions under a Section 503B compounding arrangement.","start_date":null},{"partner_name":"Medvantx","partnership_type":"strategic","description":"Serves as logistics agent, telehealth platform provider, and dispensing pharmacy for DARE to PLAY.","start_date":null}],"affiliations":[],"origin":{"leaf":"702d2480c33949313810081873c27af494265a27c9b4379d96ede5c05a9ed7e7","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"7b5abda9406bebc100ebb5ae9b41cb07a8ec004810db15272824c87f8b0577e0","parent":"ea9faadf56a7b2fa5c05913fccce7a737ba1f3a59eb2f1b208e9e0507569d17b","source":"0001401914-26-000004","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":3,"hourly_limit":500,"remaining":497,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}